ASXProposed issue of securities - IVX
other announcement
IVX
Pharmaceuticals, Biotechnology & Life Sciences
Invion
- Short interest
- 0.01%
- +0.01 pp 30d
- as of 11 Feb 2025
- Reported shorts
- 8.5K
- Shares on issue
- 70.356M
Invion (IVX) News
Latest articles and price-sensitive announcements with AI sentiment classification.
Final Director's Interest Notice - Alistair Bennallack
other announcement
Google NewsInvion (ASX:IVX) Gains 11% as Fresh Biotech Leadership Update Lands - Kalkine
Invion (ASX:IVX) Gains 11% as Fresh Biotech Leadership Update Lands Kalkine
Invion (ASX:IVX) Gains 10.81% After Fresh Biotech Leadership Appointment, but One-Year Loss Remains Steep - Kalkine
Invion (ASX:IVX) Gains 10.81% After Fresh Biotech Leadership Appointment, but One-Year Loss Remains Steep Kalkine
IVX Credentialed International Biotech Leader Joins Board
other announcement
Appendix 4C and Quarterly Activities Report - June 2026
other announcement
Global PDT Leader Dr Colin Hopper Appointed Clinical Advisor
other announcement
Change of Directors' Interest Notices x 3
director_dealing announcement
Photosoft Platform Expands to Eye Diseases Via Partnership
other announcement
Correction to Appendix 3Y - Alistair Bennallack
director_dealing announcement
Appendix 4C and Quarterly Activities Report - March 2026
other announcement
Skin Cancer Trial Moves to BCC With More Encouraging Signals
other announcement
Change of Director's Interest Notice - Thian Chew
director_dealing announcement
Appendix 4C and Quarterly Activities Report - December 2025
other announcement
Major Shareholders Lead Invion $1.3M Capital Raise
other announcement
Hanlim & Korean Government Fund Pathway to Clinical Trial
other announcement
Invion Secures Expanded Photosoft Global Exclusive License
other announcement
Appendix 4C and Quarterly Activities Report - September 2025
other announcement
Funded Collaboration Agreement with Protect Animal Health
other announcement
Repayment of Lind Facility with Successful Capital Raise
other announcement